NadiaEwingMD

PubMed

• 22 citations
  Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.
  Ara Metjian, C. Wang, Suman L. Sood, Adam Cuker, S. M. Peterson
  Haemophilia. 2009-07-10
• 350 citations
  A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
  Flora Peyvandi, Pier Mannuccio Mannucci, Isabella Garagiola, Amal El-Beshlawy, Mohsen Saleh Elalfy
  The New England Journal of Medicine. 2016-05-25
• 5 citations
  Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include Up-Regulated Innate Immune Modulators.
  Ahmad Faisal Karim, Anthony R. Soltis, Gauthaman Sukumar, Christoph Königs, Nadia P. Ewing
  Frontiers in Immunology. 2020-06-12

Journal Articles

• Consequences of Switching From Prophylactic Treatment to On Demand Treatment in Late Teens and Early Adults With Severe Hemophilia A: The TEEN/TWEN Study  
  Manco-Johnson, M, Sanders, J, Ewing, N, Rodriguez, N, Tarantino, Humphries, T and the TEEN/TWEN Study Group, Haemophilia, 1/1/2013
• Identifying Nonresponsive Bleeding Episodes in Patients with Hemophilia and Inhibitors: A Consensus Definition  
  Berntorp, E, Collins, P., D’Oiron, R., Ewing, N., Gringeri, A, Negrier, C., Young, G, Haemophilia, 1/1/2010
• Experience with a Third Generation Recombinant Factor VIII Concentrate (Advate) for Immune Tolerance induction in Patients with Hemophilia A  
  Valentino, L.,Recht,M.,DiPaola, J.,Shapiro, A.,Pipe, S., Ewing, N., Urgo, J.,Bullock, T.,Simmons, M., and Deguzman, C., Haemophilia, 1/1/2009
• The Application of Bypassing Agent Prophylaxis in Hemophilia A Patients with Inhibitors: a Meeting Report  
  Valentino, L.,Carcao, M.,Mathew, P., Leissinger, C., Berntorp, E., Blanchette, V., Escuriola-Ettingshausen, C., Ewenstein, B., Ewing. N.,Gringeri, A., Hoots, W., Negri..., Haemophilia, 1/1/2009
• Transfusion of multiple units of Js(b+) red cells in the presence of anti-Jsb in a patient with sickle beta thalassemia disease and a review of the literature  
  Yuan S, Ewing N.P., Bailey D, Salvador M, Wang S, Immunohematology, 1/1/2007
• Prophylactic treatment with activated prothrombin complex concentrate (FEIBA)reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and i...  
  Leissinger, C.A.,Becton, D.L., Ewing, N.P., Valentino, L.A., Haemophilia, 1/1/2007
• Therapeutic Choices for Patients with Hemophilia and High-Titer Inhibitors  
  Kulkarni R., Aledort L., Berntorp E., Brackman H.H., Brown D., Cohen A.R., Ewing, N.P., Gringeri A., Gruppo R., Hoots K., Leissenger C., Peerlinck K., Poon M.-C., and ..., American Journal of Hematology, 1/1/2001
• Cerebral Vasculopathy in Sickle Cell Anemia: diagnostic contribution of positron emission tomography  
  Powars D., Conti P., Wong W., Groncy P., Hyman C., Smith E., Ewing N.P, Keenan R., Zee C., Harold Y., Hiti A., Teng E., Blood, 1/1/1999
• Induction of Immune Tolerance, the Future of the Registry Review  
  Ewing, N.P., Vox Sanguinis, 1/1/1996
• Immune tolerance as treatment of alloantibodies to factor VIII in hemophilia  
  Mariani G., Scheibel E., Nogao T., Kasper C.K., Ewing N.P., Mauser-Bunschoten E., Ghirardini A., Bellocco R., and Brackman H.H., for the participants in the Internatio..., Seminars in Hematology, 1/1/1994
• Induction of Immune Tolerance with Factor VIII Concentrate in Patients with hemophilia A and Inhibitors  
  Ewing, N.P., Prog Clin Biol Res, 1/1/1990
• Comparative Efficacy of Non-heated and Heat-Treated Factor IX Complex Concentrate in Treatment of Hemophiliacs with Inhibitors  
  Schwartz R.S., Ewing N.P., Gorenc T.J., and Spero J.A., American Journal of Hematology, 1/1/1989
• Induction of Immune Tolerance to Factor VIII in Hemophiliacs with Inhibitors  
  Ewing N.P., Sanders N.L., Dietrich S.L., and Kasper C.K., JAMA, 1/1/1988
• Induction of Immune Tolerance in Hemophiliacs with Inhibitors  
  Cattaneo M., Gringeri A., Mannucci P., Ewing, N.P., Sanders N.L., Dietrich S.L., Kasper C.K., JAMA, 1/1/1988
• Acquired Inhibitors of Plasma Coagulation Factors  
  Kasper C.K., & Ewing N.P., Journal of Medical Technology, 1/1/1986
• Hematologic Management of Hemophilia A for Surgery  
  Kasper C.K., Boylen A.L., Ewing N.P., Luck J.V., Dietrich S.L., JAMA, 1/1/1985
• Altered Distribution of T-Lymphocyte Sub-population in Lymph Nodes from Patients with Acquired Immunodeficiency-like Syndrome and Hemophilia  
  Meyer P.R., Modlin R.L., Powars D., Ewing N.P.., Parker J.W., & Taylor C.R., The Journal of Pediatrics, 1/1/1983
• Neutrophilic Phagocytosis in Autoimmune Thrombocytopenia Purpura  
  Marshall G.J., Powars D., Ewing, N.P. & Kirchen M., American Journal of Pediatric Hematology/Oncology, 1/1/1982
• In Vitro Detection of Mild Inhibitors to Factor VIII in Hemophilia  
  Ewing N.P., & Kasper C.K., American Journal of Clinical Pathology, 1/1/1982
• Newborn Diagnosis of Abnormal Hemoglobins from a Large Municipal Hospital in Los Angeles  
  Ewing, N.P., Powars D.R., Hilburn J., & Schroeder W.A., American Journal of Public Health, 1/1/1981
• Issues Surrounding Genetic Screening Programs  
  Ewing, N.P., et al, American Journal of Public Health, 1/1/1981
• Bacteremia, Arthritis and Skin Lesions Due to Kingella Kingae  
  Redfield D.C., Overturf G.D., Ewing, N.P., & Powars D.R., Arch Dis Childh, 1/1/1980
• Join now to see all

Books/Book Chapters

• Therapeutic Strategies to Prevent Joint Damage in Patients with Inhibitors to Factor VIII. 
  Becton, D.L., Ewing, N.P., Valentino, L.A.Editors: Leissinger, C.A..CME Monograph2005
• Progress in Clinical Biology and Medicine 
  Chapter: Induction of Immune Tolerance with Factor VIII Concentrate. 
  Ewing, N.P.1989
• Reach for Fitness. 
  Chapter: Malignant Bone Tumors 
  Ewing, N.P.Editors: R.L. Simmons.Warner Books, Inc.1986
• Methods in Haematology: The Haemophilias. 
  Chapter: Measurement of Inhibitor of Factor VIII:C (and IX:C) 
  Kasper C.K. & Ewing, N.P.Editors: A.L. Blood.Churchill Livingstone1982
• Managing Hemophilia with Factor VIII Inhibitor. 
  Chapter: Experience with the Bethesda Assay and Other Methods of Inhibitor Detection. Activated Prothrombin Complex Concentrates 
  Kasper C.K., & Ewing, N.P.Editors: G. Mariani, M.A. Russo & F. Mandelli.1982
• Join now to see all

Abstracts/Posters

• Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include up-Regulated Innate Immune Modulators
  Nadia P Ewing, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Current Evidence For Prophylaxis in Pediatric Patients With Inhibitors.
  Ewing, N.P., Latin American Hemophilia Study Update, Cartagena, Colombia, 1/7/2014
• Transition from Pediatric to Adult Panel
  Ewing, N.P., Region IX Hemophilia Treatment Center Annual Meeting, Santa Monica, CA, 1/29/2012
• Hemophilia Research in Southern California
  Ewing, N.P., Hemophilia Treatment Center Education Day, Los Angeles, CA, 1/12/2012
• Use of recombinant factor VIIa for Bleeding and Surgeryi n Glanzmann’s Thrombasthenia and Other Platelet Disorders: An Analysis from the Hemophilia and Thrombosis Rese...
  Chitlur, M., Ewing, N.,Kraut, E., Cooper, D., Annual Scientific Symposium of the Hemostasis and Thrombosis Research Society, Chicago, IL, 1/28/2011
• Consequences of Switching from Prophylactic Treatment to on Demand Treatment in Late Teens and Early Adults with Severe Hemophilia A. The TEEN/TWEN Study.
  Manco-Johnson, M., Sanders J., Ewing N., and the TEEN/TWEN Study Group, Annual Scientific Symposium of the Hemostasis and Thrombosis Research Society, Chicago, IL, 1/28/2011
• Consequences of Switching from Prophylactic Treatment to On Demand Treatment in Late Teens and Early Adults with Severe Hemophilia A.
  Manco-Johnson, M., Sanders J., Ewing N., XXIII Congress of the International Society Of Thrombosis and Hemostsis, Kyoto, Japan, 1/23/2011
• Recombinant Factor VIIa Use in Glanzmann’s Thrombasthenia and Other Platelet Disorders: Hemophilia and Thrombosis Research Society (HTRS) Registry Data.
  Chitlur, M., Ewing, N., Kraut, E., Cooper, D., XXIII Congress of the International Society Of Thrombosis and Hemostsis, Kyoto, Japan, 1/23/2011
• Management of Inhibitor Patients with High Risk of ITI Failure: RES.I.ST Study.
  Ewing, N.P., XXIX International Congress of the World Federation of Hemophilia. Understanding FVIII/VWF complex: from Science to the Patient, Buenos Aires, Argentina, 1/13/2010
• FVIII/VWF in Inhibitor Patients at Risk for ITI Failure, or who failed ITI with FVIII.
  Ewing, N.P., National Conference on Blood Disorders in Public Health, Atlanta, GA, 1/9/2010
• FVIII/VWF in Inhibitor Patients at Risk for ITI Failure, or who failed ITI with FVIII.
  Ewing, N., Gringeri, A., Heisel-Kurth, M., Negrier, C., Hoots, W.K., Proceedings of the National Conference on Blood Disorders in Public Health, Atlanta, GA, 1/9/2010
• Mis 30 Anos de Experiencia en Cuidado de Hemophilia (Key note Address)
  Ewing, N.P., Hemophilia Spanish Family Education Day, Montecillo de Leo Politi Park, Elysian Park, Los Angeles, CA, 1/2/2010
• Inhibidores; Celebracion #2 Taller Educativo de Hemofilia
  Ewing, N.P., Hemophilia Spanish Family Education Day, Montecillo de Leo Politi Park, Elysian Park, Los Angeles, CA, 1/2/2010
• Identifying Non Responsive Bleeding Episodes in Patients with Hemophilia and Inhibitors: a Consensus Definition.
  Young, G., Berntorp, E., Collins, P., D’Oiron, R., Ewing, N., Gringeri, A., Negrier, C., ISTH, XXII Congress, Boston, MA, 1/11/2009
• VWF/FVIII Concentrates in High Risk Immunotolerance: The RESIST Studies.
  Gringeri, A, Ewing, N., Heisel-Kurth, M., Hoots, K, Negrier, C., ISTH, XXII Congress, Boston, MA, 1/11/2009
• Identifying Non Responsive Bleeding Episodes in Patients with Hemophilia and Inhibitors: a Consensus Definition.
  Young, G., Berntorp, E., Collins, P., D’Oiron, R., Ewing, N., Gringeri, A., Negrier, C., J Thromb Haemost, 1/1/2009
• VWF/FVIII Concentrates in High Risk Immunotolerance: The RESIST Studies.
  Gringeri, A, Ewing, N., Heisel-Kurth, M., Hoots, K, Negrier, C., J Thromb Haemost, 1/1/2009
• Experience with a Third Generation Recombinant Factor VIII Concentrate (Advate) for Immune Tolerance induction in Patients with Hemophilia A.
  Valentino, L.,Recht,M.,DiPaola, J.,Shapiro, A.,Pipe, S., Ewing, N., Urgo, J.,Bullock, T.,Simmons, M.,Pipe, R, and Deguzman, C., Hemophilia, 1/1/2008
• A Phase II Open Label Study Evaluating the Hemostatic Activity and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Inhibitors Directed ...
  Mahlangu,J., Andreeva, T.,MacFarlane, D.,Reding, M.,Walsh, C., Ewing, N., Kessler, C.,Kempton, C., Matthew, P., Plyushch, O., Shapiro, A., St Louis, J., Warrier, I., H..., XXVIII International Congress of the World Federation of Hemophilia Congress, Istanbul, Turkey, 1/1/2008
• Experience with a Third Generation Recombinant Factor VIII Concentrate (Advate) for Immune Tolerance induction in Patients with Hemophilia A.
  Valentino, L.,Recht,M.,DiPaola, J.,Shapiro, A.,Pipe, S., Ewing, N., Urgo, J.,Bullock, T.,Simmons, M.,Pipe, R, and Deguzman, C., XXVIII International Congress of the World Federation of Hemophilia Congress, Istanbul, Turkey, 1/1/2008
• A Phase II Open Label Study Evaluating the Hemostatic Activity and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Inhibitors Directed ...
  Mahlangu,J., Andreeva, T.,MacFarlane, D.,Reding, M.,Walsh, C., Ewing, N., Kessler, C.,Kempton, C., Matthew, P., Plyushch, O., Shapiro, A., St Louis, J., Warrier, I., H..., Hemophilia, 1/1/2008
• Transfusion of multiple units of Js(b+) red cells in the presence of anti-Jsb in a patient with sickle beta thalassemia disease.
  Yuan S, Ewing N.P., Bailey D, Salvatore M, Wang S, American Association of Blood Banking Annual Meeting, Anaheim, CA, 1/20/2007
• A Phase II Open Label Study Evaluating Hemostatic Activity, Pharmakokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloan...
  Mahlangu,J., Andreeva, T.,MacFarlane, D.,Reding, M.,Walsh, C., Ritchie, B., Ewing, N., Kessler, C.,Kempton, C., Libby, E., Zozulya, N., Shapiro, A., St Louis, J., Warr..., Blood, 1/16/2007
• Joint Preservation in Hemophiliacs with Inhibitors.
  Ewing, N.P., Hemophilia Family Information Day, sponsored by the So. CA Hemophilia Foundation, Police Academy, Los Angeles, CA, 1/14/2007
• Anamnesis in Patients with Hemophilia and Inhibitors who receive Activated Prothrombin Complex Concentrates for Prophylaxis.
  Ewing, N.P., De Guzman, C., Pullens, L, ISTH, XXI Congress, Geneva, Switzerland, 1/5/2007
• Join now to see all

Lectures

• The OB/GYN’s Role in von Willebrand Disease (VWD) Detection. 
  Pasadena, CA - 1/30/2009
• Immune Tolerance Induction in Hemophilia A and B. 
  City of Hope, Duarte, CA - 1/23/2009
• Prophylaxis in Hemophilia Patients with Inhibitors. 
  Montebello, Canada - 1/6/2009
• Immune Therapy for Inhibitors. 
  Scottsdale, AZ - 1/3/2009
• Inhibitors: Overview of Key Issues. 
  Scottsdale, AZ - 1/3/2009
• Benefits of Prophylaxis in Hemophilia Patients With and Without Inhibitors. 
  Sapporo, Japan - 1/21/2008
• Prophylaxis in Hemophiliacs with Inhibitors. 
  Tokyo Medical University, Tokyo, Japan - 1/20/2008
• Prophylaxis in Patients with Hemophia A and Inhibitors. 
  St. Marianna University, Tokyo, Japan - 1/17/2008
• ITI Study Update and status of RESIST. 
  The Langham Huntington Hotel, Pasadena, CA - 1/9/2008
• Prophylaxis in patients with Hemophilia with and without Inhibitors. 
  Loma Linda University Medical Center, Loma Linda, CA - 1/3/2008
• Inhibitors in Hemophilia. An Update. 
  City of Hope, Duarte, CA - 1/15/2007
• Therapeutic Choices in the Treatment of Hemophilia. 
  Fess Parker Doubletree Resort Hotel, Santa Barbara, CA - 1/5/2007
• The FEIBA (R) NovoSeven (R) Comparative Study (FENOC). 
  Sidney, Australia - 1/1/2007
• Prophylaxis in Hemophilia Patients with Factor VIII Inhibitors. 
  Vancouver, Canada - 1/24/2006
• Therapeutic Strategies to Prevent Joint Deterioration in Children with Hemophilia and Anti Factor VIII Antibodies VIII. 
  City of Hope National Medical Center, Duarte, CA - 1/12/2006
• Rescue Immunotolerance Study (RES.I.ST). 
  Chicago, IL - 1/11/2006
• Overweight/ Obesity. Impact on Hemophilia: HTC and Consumer Perspectives. 
  Pasadena, CA - 1/20/2005
• History of Hemophilia Care at City of Hope. 
  Pasadena, CA - 1/20/2005
• Hemophilia in Children. 
  University of Irvine, Irvine, CA - 1/24/2002
• Bleeding Disorders in Children. 
  White Memorial Hospital, Los Angeles, CA - 1/8/2002
• Transfusions in Sickle Cell Disease. 
  City of Hope National Medical Center - 1/14/2001
• Use of Recombinant factor VIIa in the Treatment of Patients with Bleeding Disorders. 
  City of Hope National Medical Center, Duarte, CA - 1/9/2001
• Homozygous Alpha Thalassemia. 
  Huntington Memorial Hospital, Pasadena, CA - 1/16/1998
• Hemorrhagic Disorders in Children. 
  Huntington Memorial Hospital, Pasadena, CA - 1/28/1997
• Childhood Thrombosis. 
  Huntington Memorial Hospital, Pasadena, CA - 1/15/1997
• Join now to see all

Other

• Strategies for Life. Prophylaxis Therapy for Hemophilia Patients with Inhibitors. Series I, II, III. 
  Ewing, N.P., Stine, K.C., Series I, II, III. CME Monographs
  http://www.myinhibitorcme.com
  1/1/2007
• AIDS – An Update (Television Program) 
  Ewing, N.P., Antenna Sud, Bari, Italy
  1/22/1998
• AIDS and Hemophilia. 
  Ewing, N.P., Antenna Sud, Bari, Italy
  1/25/1985